| Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation M Minguez, B Herreros, V Sanchiz, V Hernandez, P Almela, R Añon, ... Gastroenterology 126 (1), 57-62, 2004 | 337 | 2004 |
| Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers C FenolI-Palomares, JV Muñoz-Montagud, V Sanchiz, B Herreros, ... Revista espanola de enfermedades digestivas 96 (11), 773-783, 2004 | 333 | 2004 |
| Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy C Loras, JP Gisbert, M Mínguez, O Merino, L Bujanda, C Saro, ... Gut 59 (10), 1340-1346, 2010 | 199 | 2010 |
| Therapeutic effects of different doses of botulinum toxin in chronic anal fissure M Mínguez, F Melo, A Espí, E García-Granero, F Mora, S Lledó, ... Diseases of the colon & rectum 42 (8), 1016-1021, 1999 | 190 | 1999 |
| Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult F Mearin, C Ciriza, M Mínguez, E Rey, JJ Mascort, E Peña, P Cañones, ... Rev Esp Enferm Dig 108 (6), 332-63, 2016 | 186 | 2016 |
| Gastroesophageal reflux in diabetes mellitus I Lluch, JF Ascaso, F Mora, M Minguez, A Peña, A Hernandez, A Benages Official journal of the American College of Gastroenterology| ACG 94 (4 …, 1999 | 168 | 1999 |
| Dental and periodontal lesions in patients with gastro-oesophageal reflux disease JV Munoz, B Herreros, V Sanchiz, C Amoros, V Hernandez, I Pascual, ... Digestive and liver disease 35 (7), 461-467, 2003 | 164 | 2003 |
| Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study C Loras, C Saro, F Gonzalez-Huix, M Mínguez, O Merino, JP Gisbert, ... Official journal of the American College of Gastroenterology| ACG 104 (1), 57-63, 2009 | 160 | 2009 |
| Clinical and manometric results of endorectal advancement flaps for complex anal fistula N Uribe, M Millán, M Minguez, C Ballester, F Asencio, V Sanchiz, ... International journal of colorectal disease 22, 259-264, 2007 | 152 | 2007 |
| Recurrence of acute gallstone pancreatitis and relationship with cholecystectomy or endoscopic sphincterotomy V Hernandez, I Pascual, P Almela, R Anon, B Herreros, V Sanchiz, ... Official journal of the American College of Gastroenterology| ACG 99 (12 …, 2004 | 148 | 2004 |
| Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin M Minguez, B Herreros, V Sanchiz, F Mora, A Benages, A Espi, ... Gastroenterology 123 (1), 112-117, 2002 | 147 | 2002 |
| Activity of Crohn's disease assessed by colour Doppler ultrasound analysis of the affected loops J Esteban, L Maldonado, V Sanchiz, M Minguez, A Benages European radiology 11, 1423-1428, 2001 | 143 | 2001 |
| Elevated serum eotaxin levels in patients with inflammatory bowel disease A Mir, M Minguez, J Tatay, I Pascual, A Peña, V Sanchiz, P Almela, ... Official journal of the American College of Gastroenterology| ACG 97 (6 …, 2002 | 100 | 2002 |
| Adaptation to Spanish language and validation of the fecal incontinence quality of life scale M Minguez, V Garrigues, MJ Soria, M Andreu, F Mearin, P Clave Diseases of the colon & rectum 49 (4), 490-499, 2006 | 93 | 2006 |
| Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort study I Guerra, T Pérez-Jeldres, M Iborra, A Algaba, D Monfort, X Calvet, ... Inflammatory bowel diseases 22 (4), 894-901, 2016 | 90 | 2016 |
| Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry M Chaparro, A Garre, E Ricart, M Iborra, F Mesonero, I Vera, S Riestra, ... Alimentary pharmacology & therapeutics 48 (8), 839-851, 2018 | 89 | 2018 |
| Anal endosonographic evaluation after closed lateral subcutaneous sphincterotomy E Garcia-Granero, A Sanahuja, J Garcia-Armengol, E Jimenez, ... Diseases of the colon & rectum 41, 598-601, 1998 | 78 | 1998 |
| Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry M Iborra, B Beltrán, A Fernández‐Clotet, A Gutiérrez, B Antolín, ... Alimentary pharmacology & therapeutics 50 (3), 278-288, 2019 | 71 | 2019 |
| Adalimumab vs azathioprine in the prevention of postoperative Crohn’s disease recurrence. A GETECCU randomised trial A López-Sanromán, I Vera-Mendoza, E Domènech, C Taxonera, ... Journal of Crohn's and Colitis 11 (11), 1293-1301, 2017 | 64 | 2017 |
| Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial S Danese, S Vermeire, G d'Haens, J Panés, A Dignass, F Magro, M Nazar, ... The Lancet Gastroenterology & Hepatology 7 (4), 294-306, 2022 | 60 | 2022 |
